Close Menu

NEW YORK (360Dx) –Enable Biosciences said Thursday that it has received a Small Business Innovation Research Phase I grant for $223,806 to accelerate development of its minimally invasive blood tests for food allergy.

The San Francisco-based firm said it will use the SBIR grant received from the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop an enhanced test panel that covers 80 percent of the most common food allergens, such as milk, peanut, and shellfish.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.